Graham Lord
Vice-President and Dean of the Faculty
Graham Lord became Vice-President and Dean of the Faculty of Biology, Medicine and Health in February 2019.
He also holds the role of Executive Director of the Academic Health Science Centre as part of Health Innovation Manchester, and represents the University on the board of the Northern Health Science Alliance.
Professor Lord qualified in medicine from the University of Cambridge in 1991 and undertook a period of general clinical training as a junior doctor in Cambridge, Hammersmith, Oxford and at the Royal Brompton Hospital.
Following specialisation in nephrology, transplantation and general medicine at the Hammersmith Hospital, he undertook a period of research in molecular immunology at Imperial College London that led to a PhD in 2000, funded by an MRC Clinical Training Fellowship.
He was appointed as a Consultant in Nephrology and Transplantation at the Hammersmith in 2003. From 2003-2008, funded by an MRC Clinician Scientist award, he was a visiting scientist at Harvard University and then came back to the UK to become the Chair of Medicine at King’s College London.
He has built up a research group at King’s, investigating fundamental immune cell biology and the translation of this knowledge to the diagnosis and treatment of patients with organ transplant rejection and autoimmune diseases. As a consultant at Guy’s and St Thomas’ NHS Foundation Trust he practices clinical nephrology with a particular interest in renal and pancreatic transplantation.
He led the successful application for the NIHR BRC at Guy's and St Thomas' and was appointed as Director of the Centre in 2012. In this role, he was responsible for the delivery of programmes of translational research and experimental medicine with a significant part of the Centre's portfolio focussed on regenerative and personalised medicine, advanced therapeutics and informatics.
He was elected as an NIHR Senior Investigator in 2013 and a Fellow of the Academy of Medical Sciences in 2016. He has sat on the NIHR Strategy Board and the National Clinical Research Network Co-ordinating Centre Board. He has also advised the UK Government as a member of the Expert Advisory Group of the Accelerated Access Review, representing the BRCs across the UK.